Shire and P2M Win Telly Award for ADHD Broadcast
Shire and P2M Win Telly Award for ADHD Broadcast
YARDLEY, Pa., March 10 /PRNewswire/ -- After reviewing more than 13,000 entries, the Telly Awards® and their Silver Council announced the Shire and PharmtoMarket (P2M) produced "ADHD News Network Broadcast: 11/18/2009" had received the coveted 2010 Telly Award for video broadcasting and production.
Executive Producers for Shire, Jeff Roeseler and Nate Capone, were recognized along with Connie Ferrara of P2M for their outstanding work in producing the hour-long, live broadcast hosted by Dr. Drew Pinsky.
"The creativity and attention to detail we committed to this project were evident to the Telly Council," said Ms. Ferrara. "This award is a direct reflection of the Shire team's commitment to, and trust in, the creative process. They acted like executive producers should act: clear and absolute. It made production of a program of this caliber possible."
In addition to Dr. Pinsky as host, the program featured the talents of the leading physicians in the study and practice of ADHD and was broadcast to 58 locations throughout North America. The program was also made available via Web and teleconference.
"The combined efforts of Shire, P2M and Excerpta, resulted in an event that succeeded in bringing valuable information about new developments in the treatment of ADHD to more than 1,500 physicians," Ferrara added. "The feedback we received following the broadcast event was very positive."
The "ADHD News Network" format, a concept created by Shire's Roeseler and Capone, was the key element in delivering a program that met both the innovative and educational objectives of Shire.
"The recognition is very well-deserved," said Ms. Ferrara. "It illustrates that sharing complex medical information via both well established distance learning and contemporary digital media technologies can be engaging, interesting and compelling."
Source: PharmtoMarket
CONTACT: Connie Lo Ferrara, PharmtoMarket, +1-214-280-5231,
conniemf8@p2minc.com
-------
Profile: intent
0 Comments:
Post a Comment
<< Home